These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36915135)

  • 1. Changes in CSF sPDGFRβ level and their association with blood-brain barrier breakdown in Alzheimer's disease with or without small cerebrovascular lesions.
    Lv X; Zhang M; Cheng Z; Wang Q; Wang P; Xie Q; Ni M; Shen Y; Tang Q; Gao F;
    Alzheimers Res Ther; 2023 Mar; 15(1):51. PubMed ID: 36915135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing blood-brain barrier dysfunction and its association with Alzheimer's pathology, cognitive impairment and neuroinflammation.
    Preis L; Villringer K; Brosseron F; Düzel E; Jessen F; Petzold GC; Ramirez A; Spottke A; Fiebach JB; Peters O
    Alzheimers Res Ther; 2024 Jul; 16(1):172. PubMed ID: 39085945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers.
    Wang J; Fan DY; Li HY; He CY; Shen YY; Zeng GH; Chen DW; Yi X; Ma YH; Yu JT; Wang YJ
    Mol Neurodegener; 2022 Jan; 17(1):9. PubMed ID: 35033164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology.
    Miners JS; Kehoe PG; Love S; Zetterberg H; Blennow K
    Alzheimers Res Ther; 2019 Sep; 11(1):81. PubMed ID: 31521199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid.
    Albrecht D; Isenberg AL; Stradford J; Monreal T; Sagare A; Pachicano M; Sweeney M; Toga A; Zlokovic B; Chui H; Joe E; Schneider L; Conti P; Jann K; Pa J
    J Neurosci; 2020 Oct; 40(44):8573-8586. PubMed ID: 33046556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between Cerebrospinal Fluid Core Alzheimer's Disease Biomarkers and β-Amyloid PET in Chinese Dementia Population.
    Xie Q; Ni M; Gao F; Dai LB; Lv XY; Zhang YF; Shi Q; Zhu XX; Xie JK; Shen Y; Wang SC
    ACS Chem Neurosci; 2022 May; 13(10):1558-1565. PubMed ID: 35476397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer's disease.
    Van Hulle C; Ince S; Okonkwo OC; Bendlin BB; Johnson SC; Carlsson CM; Asthana S; Love S; Blennow K; Zetterberg H; Scott Miners J
    Transl Psychiatry; 2024 Jan; 14(1):3. PubMed ID: 38182581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Core Alzheimer's Disease Biomarkers Predict Amyloid Deposition Burden by Positron Emission Tomography in Chinese Individuals with Cognitive Decline.
    Ni M; Zhu ZH; Gao F; Dai LB; Lv XY; Wang Q; Zhu XX; Xie JK; Shen Y; Wang SC; Xie Q;
    ACS Chem Neurosci; 2023 Jan; 14(1):170-179. PubMed ID: 36547971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of blood-brain barrier leakage with cerebral small vessel disease including cerebral microbleeds in Alzheimer's disease.
    Cheng Z; Dai L; Wu Y; Cao Y; Chai X; Wang P; Liu C; Ni M; Gao F; Wang Q; Lv X
    Front Neurol; 2023; 14():1077860. PubMed ID: 36873442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. sPDGFRβ and neuroinflammation are associated with AD biomarkers and differ by race: The ASCEND Study.
    Butts B; Huang H; Hu WT; Kehoe PG; Miners JS; Verble DD; Zetterberg H; Zhao L; Trotti LM; Benameur K; Scorr LM; Wharton W
    Alzheimers Dement; 2024 Feb; 20(2):1175-1189. PubMed ID: 37933404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased functional connectivity is associated with increased levels of Cerebral Spinal Fluid soluble-PDGFRβ, a marker of blood brain barrier breakdown, in older adults.
    Contreras JA; Fujisaki K; Ortega N; Barisano G; Sagare A; Pappas I; Chui H; Ringman JM; Joe EB; Zlokovic B; Toga AW; Pa J
    Res Sq; 2023 Mar; ():. PubMed ID: 36945439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid/serum albumin quotient (Q-Alb) is not increased in Alzheimer's disease compared to neurological disease controls: a retrospective study on 276 patients.
    Giacopuzzi Grigoli E; Solca F; Milone I; Aiello EN; Dubini A; Ratti A; Torresani E; Poletti B; Ticozzi N; Ciusani E; Silani V; Verde F
    Neurol Sci; 2023 Feb; 44(2):709-713. PubMed ID: 36441343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features of Cerebral Small Vessel Disease Contributes to the Differential Diagnosis of Alzheimer's Disease.
    Cheng ZZ; Gao F; Lv XY; Wang Q; Wu Y; Sun BL; Shen Y
    J Alzheimers Dis; 2023; 91(2):795-804. PubMed ID: 36502328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease.
    Kehoe PG; Al Mulhim N; Zetterberg H; Blennow K; Miners JS
    J Alzheimers Dis; 2019; 72(2):525-535. PubMed ID: 31594235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type.
    Martino Adami PV; Orellana A; García P; Kleineidam L; Alarcón-Martín E; Montrreal L; Aguilera N; Espinosa A; Abdelnour C; Rosende-Roca M; Pablo Tartari J; Vargas L; Mauleón A; Esteban-De Antonio E; López-Cuevas R; Dalmasso MC; Campos Martin R; Parveen K; Andrade Fuentes VM; Amin N; Ahmad S; Ikram MA; Lewczuk P; Kornhuber J; Peters O; Frölich L; Rüther E; Wiltfang J; Tarraga L; Boada M; Maier W; de Rojas I; Cano A; Sanabria A; Alegret M; Hernández I; Marquié M; Valero S; van Duijn CM; Wagner M; Jessen F; Schneider A; Sáez Goñi ME; González Pérez A; Ruiz A; Ramírez A
    Brain; 2022 Jul; 145(7):2507-2517. PubMed ID: 35088840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
    Drake JD; Chambers AB; Ott BR; Daiello LA;
    J Alzheimers Dis; 2021; 80(4):1553-1565. PubMed ID: 33720880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients.
    Liguori C; Olivola E; Pierantozzi M; Cerroni R; Galati S; Saviozzi V; Mercuri NB; Stefani A
    CNS Neurol Disord Drug Targets; 2017; 16(3):339-345. PubMed ID: 27934563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma P-tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease.
    Chong JR; Ashton NJ; Karikari TK; Tanaka T; Saridin FN; Reilhac A; Robins EG; Nai YH; Vrooman H; Hilal S; Zetterberg H; Blennow K; Lai MKP; Chen CP
    Alzheimers Dement; 2021 Oct; 17(10):1649-1662. PubMed ID: 33792168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.